page_head_bg

productus

Beta CyclodExtrin cas 7585-39-9

Short description:

Product Name: Beta Cyclodextrin
CAS non.: 7585-39-9
Synonyms: β-cyclodextrin; Cyclomaltoheptaose; beta-cycloamylose; Beta-Cyclophegtaamylose; beta-dextrin
Abbreviation: BCD
Molecular Formula: C42H70O35
Molecular pondus 1134,98
Grade, PHARMACEUTICAL
Sarcina & Shipping
Stipare Detail: 1KG / peram, 2KG / peram, 20kg / pera / Carton


Product Detail

Product Tags

Specificatio

PRAECIPUUS Specificatio
Species Alba, paene odorless, denique crystallina pulveris habens leviter suavis gustum. Parce solutum in aquam
Idem IR Eodem effusio vinculis ut USP beta Cyclodextrin Rs
LC Retention tempus ad major apicem de sample solutio correspondet ad vexillum solutio
Gyratio CLX + +~+ CLXIV °
IODUM test solution A flavo-Brown Prodigit
Residuum ignition ≤ 0.1%
Reducing sugars ≤ 0.2%
Lux-absorbing impurities Inter CCXXX NM et CCCL NM, absorbance non est major 0.10; et inter CCCL NM et DCCL NM, absorbance non maius quam 0,05
Alpha cyclodextrin ≤0.25%
Gamma cyclodextrin ≤0.25%
Alterum substantias ≤0.5%
Aqua determinatio ≤14.0%
Color et claritatem solution A 10mg / ML solutio patet et hyalinae
pH 5.0 ~ 8,0
Tellus 98.0% °~102.0%
In summa aerobic microbial comitem ≤1000cfu / g
Et totalis combined fingit et yeasts comitem ≤100cfu / g

Applicatio

Beta Cyclodextrin late in separationem organicum componit et organicum synthesis, tum medical excipients et cibum additives. Et inclusion of Naturalis CyclodEtrin et mutatio CyclodEtrin et quidam medicamento moleculis qui non biocompatible nunc paratus. Non tantum auget biocompatibility de medicamento, sed etiam ludit partes sustentari release.

Comitatus

JDK habet operated vitamins et amino acidum in foro pro prope 20years, quod habet completum supplementum vinculum ex Ordine, productio, repono, mittere, Shipment et post-Sale. Diversis grades products potest esse amet. Nos semper focusing super-qualitas products, in occursum ad fora, postulationem et offer optimum servitium.

Quid nobis eligere

Quid nobis eligere

Quid possumus facere nostra clients / Partners

III

  • Previous:
  • Next: